About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,380 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,380 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5981-6000 of 11,380 trials

TerminatedAlefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host DiseaseAlefacept is a drug tht may reduce the number of T cells in circulation.NCT01226420·Boston, Massachusetts and 2 others Enrolling by invitationLow Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic ConditionsThe goal of this observational study is to assess the clinical response and the effect of autophagy function in patients before, during and throughout oral low dose sirolimus…NCT06257420·Palo Alto, California and 4 others CompletedA Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic RhinitisThe purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.NCT00720382·Oxford, Alabama and 58 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisThe two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to…NCT00195676·Birmingham, Alabama and 103 others

UnknownEffect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)The purpose of this study is to determine if an oral probiotic tablet taken once a day for twelve weeks can decrease the numbers of bacteria that are associated with tooth decay…NCT01520974·Seattle, Washington

TerminatedGlasdegib for Chronic Graft-Versus-Host DiseaseThis phase I/II trial studies whether glasdegib is helpful in treating sclerosis associated with chronic graft-versus-host disease.NCT04111497·Durham, North Carolina and 2 others

CompletedA Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesThis is a 60 week study including a double-blind phase followed by an open-label extension phase.NCT00156910·Seattle, Washington and 1 other

CompletedA Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)This study will evaluate the efficacy of VX-659 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are heterozygous for…NCT03447249·Birmingham, Alabama and 100 others

CompletedShunt Outcomes of Post-Hemorrhagic HydrocephalusThis multicenter, prospective pilot study will compare the effectiveness of two established procedures used in the treatment of post-hemorrhagic hydrocephalus in very low birth…NCT01480349·Birmingham, Alabama and 6 others

CompletedORAL T-6: Oral Androgens in Man-6We propose a study to determine the single-dose pharmacokinetics of these two novel formulations of testosterone in normal men with experimentally induced hypogonadism.NCT00663793·Seattle, Washington

CompletedSipuleucel-T as Neoadjuvant Treatment in Prostate CancerThis is an open label, Phase 2 trial of immunotherapy with sipuleucel-T as neoadjuvant treatment in men with localized prostate cancer.NCT00715104·Los Angeles, California and 6 others

TerminatedEffects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label ExtensionThis study provides an opportunity for subjects in the REFALS (3119002; NCT03505021) study to continue treatment with oral levosimendan.NCT03948178·Phoenix, Arizona and 78 others

Active not recruitingStudy Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL or SLL.NCT03331198·Birmingham, Alabama and 83 others

CompletedA Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or AblationThis study will evaluate the efficacy and safety of adjuvant therapy with atezolizumab plus bevacizumab compared with active surveillance in participants with completely resected…NCT04102098·Los Angeles, California and 133 others

CompletedEfficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart FailureThe primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived mesenchymal precursor cells (MPCs…NCT02032004·Birmingham, Alabama and 58 others

RecruitingA Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called…NCT06246916·Chandler, Arizona and 112 others

CompletedAllergic Disease Onset Prevention StudyThis is a Phase 1b/2, randomized, double-blind, multi-center study to evaluate the safety, tolerability, and preliminary clinical efficacy of STMC-103H in neonates and infants at…NCT05003804·Tucson, Arizona and 30 others

Active not recruitingA Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIVThis is a multicenter, open-label, non-randomized, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of CH505M5 N197D mRNA-gp160 and CH505 TF…NCT06557785·Boston, Massachusetts and 6 others

RecruitingARTIDIS Nanomechanical Generated Measurements for Early Breast LesionsThis prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadjuvant treatment…NCT06085833·Dallas, Texas and 5 others

RecruitingYoung Adult Education on Alcohol & HealthThe goal of this clinical trial is to test the effectiveness of our brief online program when compared to those who don't complete the program at all.NCT05620849·Seattle, Washington

PreviousPage 300 of 569Next

in Seattle

Heart Diseasein Seattle